DenovAI Biotech

Digital

Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.

News

A study of RevMed's Rasonque with Tango's vopimetostat has raised hopes of a new combination therapy for aggressive pancreatic cancer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.